Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-02-03FDA Approved: ONIVYDE — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
The FDA approved a supplemental application for ONIVYDE (liposomal irinotecan), submitted by Ipsen Biopharmaceuticals, Inc.